Surging Cancer Prevenance Drives DNA Microarray Industry

The DNA microarray market was USD 1,982.1 million in 2023, and it will increase to USD 3,930.8 million, with a 10.5% compound annual growth rate, by 2030.

This is because of the rise in the occurrence of cancer across the globe, rising use of this technology in its findings, and advancements in information technology, including software.

DNA microarray has numerous applications, including disease diagnosis & monitoring, agricultural biotechnology, protein expression & proteomics, discovery of novel medication molecules, and cancer diagnosis. The increasing funding for research purposes and the rising utilization of this technology in gene expression also boosts the industry expansion.

North America led the industry in 2023, with approximately 40% share, and the regional industry will further propel at a robust rate in the years to come. This can be mainly because of the existence of major companies in this continent and the increasing funding by them to develop technologically enhanced DNA microarray products.

APAC is expected to advance at the highest rate in the years to come. This is because of the increasing funding and contributions by both foreign and local life sciences establishments and the high incidence of cancer and various other chronic illnesses in this region.

With the mounting prevalence of cancer all across the globe, the DNA microarray industry will continue to grow in the years to come.

Read More

Medical Packaging Films Industry had a Considerable Share in the Asia-Pacific Region

According to the latest market research study published by P&S Intelligence, the total size of the medical packaging films market was USD 7,904.2 million in 2023, and it will power at a rate of 6.1% by the end of this decade, to touch  a value of USD 11,752.8 million by 2030. 

The requirement for medical packaging films is widely driven by the high requirement for medical products and apparatus in response to the growing count of patients and the mounting aging populace globally, and the beginning of improved packaging solutions to offer protection to concerned products.

An increase in healthcare spending is the main growth driver for the medical and pharma industry and hence provides a boost to the requirement for numerous protective packaging materials for suitable handling of needed products from their transit to end-use.

The high investment is due to the high predisposition of governments to invest in medical infra to offer required and cutting-edge healthcare facilities to the masses, the increasing living standards, the rising aging populace, and the growing R&D actions by companies.

APAC generated a substantial value, and it will also grow at a healthy rate of 6.5% ibn the years to come. This is credited to the growing requirement for pharma, because of the augmented healthcare outlay, improved obtainability of pharma and medical devices particularly for chronic ailment treatment, the rising aging populace, the increasing occurrence of chronic ailments, and the facility of support of the government and incentives in the region.

It is because of the increasing aging population around the world, the demand for medical packaging films is on the rise. This trend will continue in the years to come as well.

Read More

Fill-Finish Manufacturing Market is Led by the Asia-Pacific Region

The fill-finish manufacturing market made a revenue of USD 10.1 billion in 2023, and it will touch a value of USD 20.7 billion by 2030, powering at a rate of 10.9% by the end of this decade, powered by the increasing requirement for injectables, as well as biologics and modified medicines.

This procedure plays a significant role in the pharma and biotech sectors by being the last stage in the production process, wherein biologic and synthetic drugs are dispensed into their containers and packed for distribution.

On the basis of the product, consumables led the industry with a share of 65%, in 2023, and it will be like this in the future as well. Consumables put to use in in the fill−finish procedure comprise vials, cartridges, syringes, caps, seals, stoppers, and filters.

APAC was the leader of the pack, with a share of about 45%, in 2023, and this trend will continue in the years to come as well. The main region for this is that the region has a strong presence of pharma and biotech companies.

China, Japan, India, and South Korea are the hubs for pharma production and R&D activities. These have well-established pharma infra, a large and skilled workforce, and advantageous guidelines of the government supporting the development of related businesses. 

Furthermore, more than a few biotech and pharma companies from Europe and North-America outsource their final-stage production process to firms based in the region on contract.

It is because of the growing demand for injectables and continuous advancements in technology all over the world, the demand for fill-finish manufacturing is on the rise, This trend will continue in the years to come as well.

Read More

Biological Safety Cabinet Market IS Growing Considerably in Europe

The total size of the biological safety cabinet market was USD 276.8 million in 2022, which will power at a CAGR of 7.9% by the end of this decade, to touch USD 507.1 million by 2030.

To learn more about this report: https://bit.ly/3IjgsHx

In emerging countries, governments are investing profoundly for enhancing the amenities for manufacturing biologic and pharma drugs, set up new labs, and offer better healthcare. 

The developing nations are also altering their policies for the expansion of their healthcare infra budget, for encouraging the innovation of pharma products, for example vaccines.

The class II category had the largest revenue share, about 50%, in 2022, and it will maintain its dominance in the near future as well. This is because of the high acceptance of class II biosafety cabinets since they offer strong protection to the sample, along with the user and the surrounding environment.

North America dominated the biological safety cabinet market, with about 45%, as per a report published by a market research firm P&S Intelligence, and it will grow considerably in the future, because of the substantial R&D activities in the pharma and biotech industries, accompanied by the augmented risk of communicable diseases.

Furthermore, there will be a substantial growth in  Europe, with the progression of the healthcare infra and favorable policies for taking safety initiatives for their staffs and the people. Also, there is new R&D infra for boosting the growth of region which, will power the industry.

APAC has a growing prevalence of communicable diseases; therefore, reassuring the requirement for cleanroom tech solutions, such as biological safety cabinets in healthcare surroundings. 

Furthermore, the growing acceptance of cleanroom solutions for the production and packing of biotech products is supporting the industrial growth.

Because of the rising prevalence of chronic diseases all over the world, the demand for biological safety cabinets will rise even more in the future.

Read More

Innovations in Bio-Decontamination: A Closer Look at the Market and its Future Prospects

As mentioned by P&S Intelligence, in one of its reports, the total size of the bio decontamination market was USD 171.4 million in 2022, and it will reach USD 294.7 million by 2030, powering at a CAGR of 7% by the end of this decade.

Equipment category dominated the industry, with around 55% share, in the recent past. This has a lot to do with the presence of numerous equipment and benefits related to them.

The equipment should be clean and have a surface free of any debris when steam sterilization is to be done, so that the sterilant can interact with all instrument surfaces.

Hydrogen Peroxide lead the industry, with over 40%, in the recent past. Low amount of hydrogen peroxide vapor is an efficient decontaminant for numerous bacteria. VHP might not only penetrate a lot of materials but also remove germs found in joints and seams. A vapor can efficiently enter these locations by permeating them. Plastic membranes can likewise be pierced by hydrogen peroxide vapor.

North America dominated the bio decontamination market with a share of 45%.  This has a lot to do with various factors, for example increasing HAIs frequency and surgical processes and incidence of major players. The main reason for augmented surgical procedures is growing incidence of cancer. In the U.S., and Canada cancer is the second-leading mortality cause, behind heart disease.

It is because of the increased incidence of hospital acquired infection and growing number of surgical procedures, the bio contamination industry will develop like anything  in the years to come, all over the world.

Read More